German ablation registry: Cryoballoon vs radiofrequency ablation in paroxysmal atrial fibrillation—One-year outcome data
Introduction
Atrial fibrillation (AF) is associated with substantial morbidity and mortality from stroke and thromboembolism.1, 2, 3 Catheter ablation of pulmonary veins (PVs) is now well established as a curative treatment option for patients with symptomatic drug-refractory paroxysmal AF aiming at elimination or significant reduction of the AF burden.4, 5 Since the pioneering work in the late 1990s, radiofrequency (RF) technology has been the standard of care with evolving ablation strategies.6, 7 RF point-by-point ablation has shown high success rates in the treatment of patients with paroxysmal AF and persistent AF but is limited by several potential procedure-related complications, such as PV stenosis, pericardial effusion, atrio-esophageal fistula, thromboembolism, and left atrial (LA) flutter despite novel technologies.8, 9, 10, 11
The development of balloon catheters has enabled several new PV isolation strategies using cryotherapy, focused ultrasound, or endoscopic laser.12 Furthermore, cryoballoon therapy (Arctic Front, Medtronic, Minneapolis, MN) enables expeditious, complete, and safe circumferential isolations of the PV with proven low thrombogeneity.12, 13, 14 However, current available data with the cryoballoon therapy are primarily based on feasibility and nonrandomized clinical trials.15, 16, 17
Our group recently reported procedural parameters of the German ablation registry.18 Prospective multicenter registry outcome data referring to both ablation technologies in AF ablation therapy are lacking so far. Therefore, we report on the 1-year outcome data of all paroxysmal AF patients included in the German ablation registry with respect to efficacy and clinical outcome.
Section snippets
Study design and recruiting centers
The German ablation registry is a multicenter prospective registry including a total of 55 German electrophysiology centers. Registry approval of the local ethical committees was obtained.
The aim of the study was to monitor the current use and outcome of PV ablation methods, including RF ablation and cryoballoon ablation, in patients with paroxysmal AF in daily clinical practice. The registry was driven by the scientific interest of the participating hospitals and conducted by the Institut für
Patients characteristics and severity of AF-related symptoms
A total of 2306 patients (median age 62 [53–68] years, 1465 [63.5%] male) were included in the study. The proportion of males was similar in the RF and cryoballoon groups (63.3% vs 64.3%, P = .67). Patient characteristics did not differ significantly between both groups. An overview of comorbidities and patient characteristics is given in Table 1.
Symptomatic AF episodes before inclusion in the registry showed no significant differences between both groups. In patients undergoing RF ablation,
Discussion
The present analysis of the German ablation registry addresses a comparison of the cryoballoon approach with RF ablation in paroxysmal AF patients. Because ablation techniques and strategies vary among centers, it is of upmost interest to compare data on different ablation approaches, not only in selected patients in high-volume centers but in a setting that more closely reflects the practicing trend.
Conclusion
Freedom from AF recurrence 1 year after a single AF ablation using RF energy or cryoenergy in the “real-world” setting of the German ablation registry was lower than that of previously published trials of paroxysmal AF patients. Overall complication rates were similar, but the spectrum and type of complications differed significantly between the two ablation methods. These findings might have an impact on the choice of ablation method offered to the individual AF patient.
References (35)
- et al.
Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation
J Am Coll Cardiol
(2008) - et al.
Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis
J Am Coll Cardiol
(2003) - et al.
The safety and efficacy of multiple consecutive cryo lesions in canine pulmonary veins-left atrial junction
Heart Rhythm
(2004) - et al.
Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study
J Am Coll Cardiol
(2008) - et al.
Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies
Heart Rhythm
(2011) - et al.
Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence rates and pulmonary vein reconnection pattern
Heart Rhythm
(2010) - et al.
Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation
Heart Rhythm
(2014) - et al.
Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation
J Am Coll Cardiol
(2009) - et al.
Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front STOP AF pivotal trial
J Am Coll Cardiol
(2013) - et al.
Temporal relation of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study
Circulation
(2003)
Epidemiology and significance of atrial fibrillation
Am J Cardiol
Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation
Circ Arrhythm Electrophysiol
Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses
Circ Arrhythm Electrophysiol
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
N Engl J Med
State-of-the-art and evolving technologies for atrial fibrillation ablation
Nat Rev Cardiol
Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy
Circulation
Complications of atrial fibrillation ablation in a high volume center in 1000 procedures: still cause for concern?
J Cardiovasc Electrophysiol
Cited by (58)
Clinical outcome of a single procedure cryoballoon ablation for the treatment of atrial fibrillation: A real-world multicenter experience in Portugal
2023, Revista Portuguesa de CardiologiaSpanish catheter ablation registry. 21st official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2021)
2022, Revista Espanola de CardiologiaEmergency department attendance and reasons for consultation after cryoballoon ablation for pulmonary vein isolation of atrial fibrillation
2021, Revista Espanola de Cardiologia
The 1-year follow-up and a former publication were partially supported by unrestricted grants from Medtronic, Biosense Webster, and Biotronik.